Vital Chemtech reported a mixed set of results for Q4 FY26 and the full year FY26, with steady revenue but pressure on profitability as the company continued to invest heavily in its subsidiary expansion strategy.
Revenue from operations for Q4 FY26 stood at Rs. 35.1 crore, largely unchanged year-on-year, signaling steady demand despite ongoing global headwinds.
Operating performance, however, strengthened significantly. EBITDA surged 39.7% YoY to Rs. 4.0 crore, with margins expanding by 320 basis points to 11.3%, driven by operational efficiencies and improved cost management.
Net profit told a different story. Profit After Tax (PAT) declined 28.2% YoY to Rs. 0.8 crore, with margins narrowing to 2.4%. The company attributed the drop primarily to investments in its subsidiaries, Vital Synthesis and Vital Alkoxides.
For the full year FY26, revenue from operations fell 5.6% YoY to Rs. 126.4 crore.
EBITDA also declined 5.6% to approximately Rs. 10.0 crore, though margins remained stable at 7.9%, unchanged from FY25—highlighting underlying operational consistency despite top-line pressure.
Profitability weakened more sharply. PAT dropped to Rs. 1.0 crore from Rs. 4.0 crore in FY25, reducing PAT margin to 0.8% from 3.0%. The company again pointed to ongoing investments in its subsidiary businesses as the key factor impacting earnings.
Despite short-term profit pressure, the company emphasized its strategic build-out of its specialty chemicals platform.
During FY26, the company’s subsidiaries continued to strengthen the group’s long-term growth platform and specialty chemicals portfolio.”
Vital Synthesis Limited, which began commercial operations in Q3 FY26, has seen early customer traction with gradual scale-up expected as acceptance grows.
Vital Alkoxides Private Limited delivered standout performance, posting ~63% YoY revenue growth during the year, underscoring strong demand momentum.
Commenting on the results, Chairman and Managing Director Vipul Bhatt said the company is prioritizing long-term value creation over near-term profitability.
“In FY26, Vital Chemtech focused on strengthening its business foundation through strategic investments, operational improvements, and expansion across specialty chemical segments. Despite challenging global market conditions, the company demonstrated resilience with stable revenue performance and improved operational efficiencies during Q4 FY26.
"During the year, the company continued to invest in its subsidiaries, Vital Synthesis Limited and Vital Alkoxides Private Limited, with a long-term vision of expanding its presence in high-growth specialty chemical markets. While these investments impacted short-term profitability, they are expected to strengthen the group’s growth platform, diversification strategy, and future earnings potential.
"The company remains focused on improving capacity utilization, optimizing product mix, strengthening customer relationships, and expanding its portfolio of value-added specialty chemical products.”
He added that the company’s integrated Dahej manufacturing facility and expanding capabilities position it for future growth across domestic and export markets.
